Market Research Logo

Generic Pharmaceutical Manufacturing in the US - Industry Market Research Report


Attention: There is an updated edition available for this report.

Generic Pharmaceutical Manufacturing in the US

The Generic Pharmaceutical Manufacturing industry is expanding rapidly. An aging population with more chronic illnesses is driving demand for industry products, while regulatory provisions of the Patient Protection and Affordable Care Act expand consumer access to prescription insurance and provide increased opportunities for product development. In the past five years, industry revenue growth has outpaced revenue growth for the Brand Name Pharmaceutical Manufacturing industry (IBISWorld report 32541a). Many brand name manufacturers lost patent protection for blockbuster drugs beginning in 2010; demand for generics subsequently grew, as consumers demanded affordable versions of these high-profile products. These trends will likely continue in the next five years. However, while patent expirations have benefited industry revenue, they have also induced brand name manufacturers to cut costs, including research and development (R&D) spending. Lower R&D spending by brand name manufacturers decreases the total number of new pharmaceutical products coming off these manufacturers' drug pipelines, threatening the long-term viability of generics.Generic pharmaceutical and medicine manufacturers develop prescription and over-the-counter drug products that are used to prevent or treat illnesses in humans or animals. Generic drugs are produced and distributed without patent protection, and industry operators are not significantly engaged in the research and development of new drugs. The industry does not include manufacturers of nutritional supplements or cosmetic beauty products.

This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.


  • About this Industry
  • Industry at a Glance
    • Table Key Statistics Snapshot
    • Table Revenue vs. employment growth
    • Table Products and services segmentation (2016)
    • Table Industry Structure
  • Industry Performance
    • Table Federal funding for Medicare and Medicaid
    • Table Industry revenue
    • Table Life Cycle Stage
  • Products & Markets
    • Table KEY BUYING INDUSTRIES
    • Table KEY SELLING INDUSTRIES
    • Table Products and services segmentation (2016)
    • Table Major market segmentation (2016)
    • Table Industry trade balance
    • Table Exports To
    • Table Business Locations 2016
    • Table Distribution of establishments vs. population
  • Competitive Landscape
    • Table Sector vs. Industry Costs
    • Table Barriers to Entry checklist
    • Table Trade Globalization
  • Major Companies
    • Table Major players
    • Table Mylan (US industry-relevant operations) - financial performance*
    • Table Teva Pharmaceutical (US industry-relevant operations) - financial performance
    • Table Sandoz (industry-relevant operations) - financial performance
  • Operating Conditions
    • Table Capital intensity
    • Table Tools of the Trade: Growth Strategies for Success
    • Table Volatility vs Growth
  • Key Statistics
    • Table Industry Data
    • Table Annual Change
    • Table Key Ratios
    • Table Industry Financial Ratios
  • Jargon & Glossary

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report